Cold & Cough Remedies (Pharmacies) - El Salvador

  • El Salvador
  • Revenue in the Cold & Cough Remedies market is projected to reach US$5.69m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.65%, resulting in a market volume of US$7.85m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.89 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in El Salvador is experiencing steady growth due to changing customer preferences and local special circumstances.

Customer preferences:
Customers in El Salvador are increasingly seeking over-the-counter remedies for cold and cough symptoms. This shift in preference can be attributed to several factors. Firstly, there is a growing awareness among consumers about the effectiveness and convenience of self-medication for common ailments. Secondly, the rising healthcare costs and limited access to healthcare facilities have led consumers to rely more on pharmacies for their healthcare needs. Finally, the availability of a wide range of cold and cough remedies in pharmacies allows customers to choose products that suit their specific needs.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in El Salvador is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived to be safer and have fewer side effects. This trend is in line with the global shift towards natural and alternative medicines. As a result, pharmacies are expanding their product offerings to include a variety of natural remedies such as herbal teas, essential oils, and homeopathic remedies. Another trend in the market is the growing popularity of combination products. Customers are looking for remedies that provide relief from multiple symptoms, such as congestion, cough, and sore throat, in a single product. This trend is driven by the desire for convenience and cost-effectiveness. Combination products not only simplify the treatment process but also reduce the need for customers to purchase multiple individual remedies.

Local special circumstances:
El Salvador has a high prevalence of respiratory diseases, including colds and coughs. This can be attributed to various factors such as pollution, poor air quality, and a lack of proper healthcare facilities. As a result, the demand for cold and cough remedies is consistently high in the country. Additionally, the tropical climate of El Salvador, with its high humidity and temperature, creates favorable conditions for the spread of respiratory infections, further driving the demand for remedies.

Underlying macroeconomic factors:
The growing middle class and increasing disposable incomes in El Salvador are contributing to the growth of the Cold & Cough Remedies market. As people have more money to spend on healthcare, they are willing to invest in over-the-counter remedies to alleviate their cold and cough symptoms. Furthermore, the expanding pharmaceutical industry and the presence of multinational companies in the country are driving the availability and accessibility of cold and cough remedies in pharmacies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in El Salvador is witnessing growth due to changing customer preferences, including the demand for natural and combination products. The local special circumstances, such as the high prevalence of respiratory diseases and the tropical climate, also contribute to the market's development. Additionally, the underlying macroeconomic factors, such as the growing middle class and increasing disposable incomes, further support the growth of the market in El Salvador.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)